Financhill
Buy
56

ALGN Quote, Financials, Valuation and Earnings

Last price:
$181.80
Seasonality move :
3.1%
Day range:
$184.94 - $189.72
52-week range:
$141.74 - $271.59
Dividend yield:
0%
P/E ratio:
33.79x
P/S ratio:
3.47x
P/B ratio:
3.54x
Volume:
612.8K
Avg. volume:
964.8K
1-year change:
-26.77%
Market cap:
$13.4B
Revenue:
$4B
EPS (TTM):
$5.49

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ALGN
Align Technology
$975.8M $1.99 2.9% 100.44% $227.30
BSX
Boston Scientific
$4.6B $0.67 18.78% 229.3% $117.02
MLSS
Milestone Scientific
$2.5M -$0.01 40.26% -50% $2.13
NVST
Envista Holdings
$606.4M $0.20 0.62% 46.34% $19.04
SOLV
Solventum
$2B $1.22 1.89% 185.16% $82.17
XRAY
Dentsply Sirona
$853.9M $0.30 -5.77% 234.18% $18.14
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ALGN
Align Technology
$185.48 $227.30 $13.4B 33.79x $0.00 0% 3.47x
BSX
Boston Scientific
$99.40 $117.02 $147.1B 72.55x $0.00 0% 8.43x
MLSS
Milestone Scientific
$0.89 $2.13 $69.9M -- $0.00 0% 8.28x
NVST
Envista Holdings
$19.23 $19.04 $3.3B -- $0.00 0% 1.33x
SOLV
Solventum
$74.41 $82.17 $12.9B 34.45x $0.00 0% 1.56x
XRAY
Dentsply Sirona
$16.11 $18.14 $3.2B -- $0.16 3.97% 0.87x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ALGN
Align Technology
-- 2.173 -- 0.99x
BSX
Boston Scientific
33.49% 0.843 7.48% 0.68x
MLSS
Milestone Scientific
-- 1.937 -- 0.62x
NVST
Envista Holdings
31.74% 1.812 47.7% 1.68x
SOLV
Solventum
70.81% 0.887 60.15% 0.64x
XRAY
Dentsply Sirona
53.74% 1.023 78.42% 0.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ALGN
Align Technology
$680.1M $135.3M 10.72% 10.72% 13.81% $27.4M
BSX
Boston Scientific
$3.2B $937M 6.35% 9.57% 19.02% $277M
MLSS
Milestone Scientific
$1.6M -$2M -79.98% -79.98% -89.49% -$1M
NVST
Envista Holdings
$336M $47.4M -24.02% -34.78% 6.21% -$5.6M
SOLV
Solventum
$1.1B $152M 3.34% 11.75% 6.86% -$80M
XRAY
Dentsply Sirona
$466M $70M -19.2% -35.57% 7.17% -$12M

Align Technology vs. Competitors

  • Which has Higher Returns ALGN or BSX?

    Boston Scientific has a net margin of 9.52% compared to Align Technology's net margin of 14.45%. Align Technology's return on equity of 10.72% beat Boston Scientific's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    BSX
    Boston Scientific
    68.84% $0.45 $33.6B
  • What do Analysts Say About ALGN or BSX?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 22.55%. On the other hand Boston Scientific has an analysts' consensus of $117.02 which suggests that it could grow by 17.73%. Given that Align Technology has higher upside potential than Boston Scientific, analysts believe Align Technology is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    BSX
    Boston Scientific
    23 3 0
  • Is ALGN or BSX More Risky?

    Align Technology has a beta of 1.643, which suggesting that the stock is 64.323% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.681, suggesting its less volatile than the S&P 500 by 31.908%.

  • Which is a Better Dividend Stock ALGN or BSX?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or BSX?

    Align Technology quarterly revenues are $979.3M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Align Technology's net income of $93.2M is lower than Boston Scientific's net income of $674M. Notably, Align Technology's price-to-earnings ratio is 33.79x while Boston Scientific's PE ratio is 72.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.47x versus 8.43x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.47x 33.79x $979.3M $93.2M
    BSX
    Boston Scientific
    8.43x 72.55x $4.7B $674M
  • Which has Higher Returns ALGN or MLSS?

    Milestone Scientific has a net margin of 9.52% compared to Align Technology's net margin of -89.35%. Align Technology's return on equity of 10.72% beat Milestone Scientific's return on equity of -79.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    MLSS
    Milestone Scientific
    73.8% -$0.02 $4.5M
  • What do Analysts Say About ALGN or MLSS?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 22.55%. On the other hand Milestone Scientific has an analysts' consensus of $2.13 which suggests that it could grow by 138.71%. Given that Milestone Scientific has higher upside potential than Align Technology, analysts believe Milestone Scientific is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    MLSS
    Milestone Scientific
    1 0 0
  • Is ALGN or MLSS More Risky?

    Align Technology has a beta of 1.643, which suggesting that the stock is 64.323% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 0.902, suggesting its less volatile than the S&P 500 by 9.838%.

  • Which is a Better Dividend Stock ALGN or MLSS?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or MLSS?

    Align Technology quarterly revenues are $979.3M, which are larger than Milestone Scientific quarterly revenues of $2.2M. Align Technology's net income of $93.2M is higher than Milestone Scientific's net income of -$2M. Notably, Align Technology's price-to-earnings ratio is 33.79x while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.47x versus 8.28x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.47x 33.79x $979.3M $93.2M
    MLSS
    Milestone Scientific
    8.28x -- $2.2M -$2M
  • Which has Higher Returns ALGN or NVST?

    Envista Holdings has a net margin of 9.52% compared to Align Technology's net margin of 2.92%. Align Technology's return on equity of 10.72% beat Envista Holdings's return on equity of -34.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    NVST
    Envista Holdings
    54.47% $0.10 $4.4B
  • What do Analysts Say About ALGN or NVST?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 22.55%. On the other hand Envista Holdings has an analysts' consensus of $19.04 which suggests that it could fall by -0.98%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    NVST
    Envista Holdings
    4 9 1
  • Is ALGN or NVST More Risky?

    Align Technology has a beta of 1.643, which suggesting that the stock is 64.323% more volatile than S&P 500. In comparison Envista Holdings has a beta of 0.995, suggesting its less volatile than the S&P 500 by 0.5%.

  • Which is a Better Dividend Stock ALGN or NVST?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or NVST?

    Align Technology quarterly revenues are $979.3M, which are larger than Envista Holdings quarterly revenues of $616.9M. Align Technology's net income of $93.2M is higher than Envista Holdings's net income of $18M. Notably, Align Technology's price-to-earnings ratio is 33.79x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.47x versus 1.33x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.47x 33.79x $979.3M $93.2M
    NVST
    Envista Holdings
    1.33x -- $616.9M $18M
  • Which has Higher Returns ALGN or SOLV?

    Solventum has a net margin of 9.52% compared to Align Technology's net margin of 6.62%. Align Technology's return on equity of 10.72% beat Solventum's return on equity of 11.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    SOLV
    Solventum
    53.82% $0.78 $11.2B
  • What do Analysts Say About ALGN or SOLV?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 22.55%. On the other hand Solventum has an analysts' consensus of $82.17 which suggests that it could grow by 10.42%. Given that Align Technology has higher upside potential than Solventum, analysts believe Align Technology is more attractive than Solventum.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    SOLV
    Solventum
    1 8 0
  • Is ALGN or SOLV More Risky?

    Align Technology has a beta of 1.643, which suggesting that the stock is 64.323% more volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ALGN or SOLV?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or SOLV?

    Align Technology quarterly revenues are $979.3M, which are smaller than Solventum quarterly revenues of $2.1B. Align Technology's net income of $93.2M is lower than Solventum's net income of $137M. Notably, Align Technology's price-to-earnings ratio is 33.79x while Solventum's PE ratio is 34.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.47x versus 1.56x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.47x 33.79x $979.3M $93.2M
    SOLV
    Solventum
    1.56x 34.45x $2.1B $137M
  • Which has Higher Returns ALGN or XRAY?

    Dentsply Sirona has a net margin of 9.52% compared to Align Technology's net margin of 2.28%. Align Technology's return on equity of 10.72% beat Dentsply Sirona's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
  • What do Analysts Say About ALGN or XRAY?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 22.55%. On the other hand Dentsply Sirona has an analysts' consensus of $18.14 which suggests that it could grow by 12.62%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    XRAY
    Dentsply Sirona
    2 13 0
  • Is ALGN or XRAY More Risky?

    Align Technology has a beta of 1.643, which suggesting that the stock is 64.323% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.948, suggesting its less volatile than the S&P 500 by 5.215%.

  • Which is a Better Dividend Stock ALGN or XRAY?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 3.97% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or XRAY?

    Align Technology quarterly revenues are $979.3M, which are larger than Dentsply Sirona quarterly revenues of $879M. Align Technology's net income of $93.2M is higher than Dentsply Sirona's net income of $20M. Notably, Align Technology's price-to-earnings ratio is 33.79x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.47x versus 0.87x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.47x 33.79x $979.3M $93.2M
    XRAY
    Dentsply Sirona
    0.87x -- $879M $20M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet or Amazon the Better Buy?
Is Alphabet or Amazon the Better Buy?

Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
OKLO alert for Jun 12

Oklo [OKLO] is down 5.6% over the past day.

Buy
87
SMR alert for Jun 12

NuScale Power [SMR] is down 2.96% over the past day.

Buy
53
PLAY alert for Jun 12

Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock